Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial-Reference-Cited by-同舟云学术

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

Published:2010-10 Issue:10 Volume:11 Page:950-961
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Lipshultz Steven E,Scully Rebecca E,Lipsitz Stuart R,Sallan Stephen E,Silverman Lewis B,Miller Tracie L,Barry Elly V,Asselin Barbara L,Athale Uma,Clavell Luis A,Larsen Eric,Moghrabi Albert,Samson Yvan,Michon Bruno,Schorin Marshall A,Cohen Harvey J,Neuberg Donna S,Orav E John,Colan Steven D

Publisher

Elsevier BV

Subject

Oncology

Reference91 articles.

1. Results of the Dana–Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia;Moghrabi;Blood,2007

2. Improved outcome for children with acute lymphoblastic leukemia: results of Dana–Farber Consortium Protocol 91-01;Silverman;Blood,2001

3. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group;Schrappe;Blood,2000

4. Treating childhood acute lymphoblastic leukemia without cranial irradiation;Pui;N Engl J Med,2009

5. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995;Gaynon;Leukemia,2000

Cited by 370 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of cardiotoxicity in childhood cancer survivors: In physical exercise, we trust;Current Problems in Cardiology;2024-09

2. The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review);Drug development & registration;2024-08-26

3. Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I study;eClinicalMedicine;2024-07

4. Aucubin alleviates doxorubicin-induced cardiotoxicity through crosstalk between NRF2 and HIPK2 mediating autophagy and apoptosis;Phytomedicine;2024-05

5. 5-Hydroxytryptophan acts as a gap junction inhibitor to limit the spread of chemotherapy-induced cardiomyocyte injury and mitochondrial dysfunction;Aging;2024-03-10